>The vaccinated now account for a majority of COVID deaths.
Sad. Anons were discussing antibody dependent enhancement years ago. Perhaps [their] dengvaxia experiment was the trial run.
"Antibody dependent enhancement(ADE) after COVID vaccination can increase the severity of SARS-COV-2 infection. We present a case of acute respiratory failure where ADE secondary to COVID vaccination may have played a role in the patient's fatal illness."
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548747/#:~:text=INTRODUCTION: Antibody dependent enhancement(ADE,in the patient's fatal illness.
"antibodies, intended to protect the host, may sometimes prove beneficial to the virus, by facilitating viral entry and replication in the target cell. This phenomenon, known as antibody-dependent enhancement (ADE) of infection, is a result of interaction of virus–antibody immune complexes with Fcγ and/or complement receptors on certain types of host cells and promotes viral entry into the host cells. The internalized immune complexes then modulate host immune response so as to enhance viral replication and aggravate disease severity. The possibility of induction of ADE remains a concern in the development and implementation of viral vaccines…"
https://link.springer.com/chapter/10.1007/978-981-15-1045-8_2
The Dengvaxia controversy occurred in the Philippines when the dengue vaccine Dengvaxia was found to increase the risk of disease severity for some people who had received it.
A vaccination program run by the Philippine Department of Health (DOH) administered Sanofi Pasteur's Dengvaxia to schoolchildren. The program was stopped when Sanofi Pasteur advised the government that the vaccine could put previously uninfected people at a somewhat higher risk of a severe case of dengue fever through antibody-dependent enhancement. A political controversy erupted over whether the program was run with sufficient care and who should be held responsible for the alleged harm to the vaccinated children.
In late November 2017, the DOH suspended the school-based vaccination program. The DOH subsequently banned the vaccine's use and sale in the Philippines. The scare caused by the controversy has been suggested as a factor in the country's loss of confidence in vaccines and low immunization rates, resulting in an infectious disease crisis in the country in 2019, including a measles outbreak.
https://en.wikipedia.org/wiki/Dengvaxia_controversy